Company Filing History:
Years Active: 2011-2013
Title: Asim Ray: Innovator in Pharmaceutical Chemistry
Introduction
Asim Ray is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit human neutrophil elastase. With a total of 3 patents to his name, Ray's work is pivotal in advancing therapeutic options for various diseases.
Latest Patents
Ray's latest patents focus on 2-pyrazinone derivatives that are beneficial in treating diseases where the inhibition of neutrophil elastase activity is crucial. The inventions provide compounds of a specific formula, including optical isomers, racemates, tautomers, and pharmaceutically acceptable salts. These compounds are designed to inhibit human neutrophil elastase, offering new avenues for therapeutic applications.
Career Highlights
Asim Ray is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative research and development in the pharmaceutical sector. His expertise in creating effective inhibitors has positioned him as a key player in the industry.
Collaborations
Ray has collaborated with esteemed colleagues such as Peter Hansen and Karolina Lawitz. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Asim Ray's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for advancements in medical treatments.